Watch for patient enrollment start in the OcuRing™-K Phase 2 trial before year-end and any strategic partnership announcements for GridFeed. The activist 13D adds overhang — monitor for a special meeting or board changes in the coming weeks.
Price Chart
Executive Summary
PRF Technologies issued a shareholder letter highlighting a strengthened balance sheet with $11M cash and $2.5M liabilities, plans to start a Phase 2 trial for OcuRing™-K before year-end, and the establishment of GridFeed as a standalone subsidiary targeting AI data center power optimization. The filing provides operational updates but no formal earnings results, and the activist 13D filed 29 days ago adds pressure for board changes.
Key Facts
- Preliminary unaudited cash of ~$11.0M and total liabilities of ~$2.5M as of Sep 30, 2026
- Raised ~$10.5M gross via equity line facility in 9M 2026, including ~$0.5M in Q3
- Consolidated operating loss of ~$3.7M for 9M 2026 (preliminary, unaudited)
- LayerBio expects to start enrolling patients in U.S. Phase 2 trial of OcuRing™-K before year-end
- GridFeed to be established as standalone wholly owned subsidiary; exploring AI/data center power optimization market
- Activist S.H.N. Financial Investments (5.716% stake) filed 13D on Sep 24 demanding board changes
Financial Impact
Cash position of ~$11M provides runway for near-term operations; operating loss of ~$3.7M over 9 months implies ~$1.2M quarterly burn
Risk Factors
- Preliminary financials are unaudited and may materially differ from final audited results
- Phase 2 trial enrollment may be delayed; clinical failure risk remains high for early-stage biotech
- GridFeed subsidiary structure and data center pivot are unproven; no material revenue yet
- Activist pressure could lead to board disruption or forced strategic actions
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3387278 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 6-K | $0.7400 | awaiting T+60 | — | $0.7393 (−0.09%) |
Oct 23, 2026 3d ago | Press Release | $0.7400 | awaiting T+60 | — | $0.7393 (−0.09%) |
Sep 28, 2026 28d ago | 6-K | $0.9720 | awaiting T+60 | — | $0.7393 (−23.94%) |
Sep 24, 2026 4w ago | SC 13D | $0.9767 | awaiting T+60 | — | $0.7393 (−24.31%) |
Sep 16, 2026 5w ago | 6-K | $1.01 | awaiting T+60 | — | $0.7393 (−26.80%) |
Sep 4, 2026 7w ago | EFFECT | $0.9680 | awaiting T+60 | — | $0.7393 (+23.63%) |
Sep 3, 2026 7w ago | 6-K | $0.9792 | awaiting T+60 | — | $0.7393 (−24.50%) |
Sep 3, 2026 7w ago | Press Release | $0.9792 | awaiting T+60 | — | $0.7393 (−24.50%) |
Jul 27, 2026 13w ago | 6-K | $1.09 $0.7120 | ▼ −34.68% | ▼ −38.38% | $0.7393 (−32.17%) |
Jul 21, 2026 13w ago | 6-K | $1.20 $0.8180 | ▼ −31.83% | ▼ −35.81% | $0.7393 (−38.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers